Pyrrolidine → pyrrolidino-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
Reaction equation
C([N:3]1[C:9]2[N:10]=[CH:11][CH:12]=[CH:13][C:8]=2[C:7](=[O:14])[N:6](C)[C:5]2[CH:16]=[CH:17][C:18](OS(C(F)(F)F)(=O)=O)=[N:19][C:4]1=2)C.[NH:28]1[CH2:32][CH2:31][CH2:30][CH2:29]1>C(OCC)(=O)C>[N:28]1([C:18]2[CH:17]=[CH:16][C:5]3[C:4]([N:19]=2)=[N:3][C:9]2[N:10]=[CH:11][CH:12]=[CH:13][C:8]=2[C:7](=[O:14])[N:6]=3)[CH2:32][CH2:31][CH2:30][CH2:29]1Participants
4
Procedure
5,11-Dihydro-11-ethyl-5-methyl-2-trifluoromethanesulfonyloxy-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one (0.25 g) was dissolved in pyrrolidine (1 ml) and refluxed 30 min. The cooled solution was diluted with ethyl acetate, washed with water, and the organic phase was dried (anhydrous magnesium sulfate) and concentrated. The resulting oily residue was crystallized from ethyl acetate/hexane to provide 0.11 g of 5,11-dihydro-11-ethyl-5-methyl-2-n-(pyrrolidino-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, m.p. 185°-188° C.
Workup
- temperaturerefluxed 30 min
- washwashed with water
- dry with materialthe organic phase was dried (anhydrous magnesium sulfate)
- concentrationconcentrated
- customThe resulting oily residue was crystallized from ethyl acetate/hexane
Sources & evidence
- ORD record
- ord-fa1bcef2de084958b1cea21000e2dac9
- Source dataset
- uspto-grants-1994_11
- Patent number
- US05366972
Reaction notes
Loading…